NasdaqGM - Delayed Quote USD
Vericel Corporation (VCEL)
39.42
-1.45
(-3.55%)
At close: April 22 at 4:00:01 PM EDT
39.42
0.00
(0.00%)
After hours: April 22 at 4:36:17 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.15 | -0.03 | 0.32 | 0.77 |
| Low Estimate | -0.25 | -0.08 | 0.26 | 0.6 |
| High Estimate | -0.06 | 0 | 0.43 | 0.87 |
| Year Ago EPS | -0.08 | -0.1 | 0.2 | 0.32 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 53.86M | 65.05M | 286.63M | 356.55M |
| Low Estimate | 52.7M | 63.9M | 285M | 341.9M |
| High Estimate | 54.87M | 66.5M | 288.55M | 389.21M |
| Year Ago Sales | 51.28M | 52.66M | 237.22M | 286.63M |
| Sales Growth (year/est) | 5.03% | 23.52% | 20.83% | 24.40% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.1 | -0.09 | -0.05 | 0.34 |
| EPS Actual | -0.08 | -0.1 | 0.02 | 0.38 |
| Difference | 0.02 | -0.01 | 0.06 | 0.04 |
| Surprise % | 17.95% | -9.09% | 140.00% | 11.76% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.15 | -0.03 | 0.32 | 0.77 |
| 7 Days Ago | -0.13 | -0.02 | 0.3 | 0.75 |
| 30 Days Ago | -0.13 | -0.02 | 0.3 | 0.75 |
| 60 Days Ago | 0.03 | 0.01 | 0.47 | 0.93 |
| 90 Days Ago | 0.02 | 0.02 | 0.53 | 0.9 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | 1 |
| Up Last 30 Days | 1 | 1 | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VCEL | -91.66% | 71.67% | 61.66% | 138.15% |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 4/11/2025 |
| Reiterates | Truist Securities: Buy to Buy | 3/3/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/28/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/3/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 1/15/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/15/2025 |
Related Tickers
MDWD MediWound Ltd.
17.95
+1.70%
KRYS Krystal Biotech, Inc.
168.80
+4.26%
CELU Celularity Inc.
1.4900
-1.32%
MSB.AX Mesoblast Limited
1.7000
+5.59%
CPRX Catalyst Pharmaceuticals, Inc.
22.60
+2.63%
ZYME Zymeworks Inc.
12.16
+3.49%
CLRB Cellectar Biosciences, Inc.
0.3028
+4.34%
SAGE Sage Therapeutics, Inc.
7.68
+3.23%
CDTX Cidara Therapeutics, Inc.
21.98
+6.26%
LCTX Lineage Cell Therapeutics, Inc.
0.4298
+7.45%